ReWalk Robotics Ltd. (LFWD)

USD 1.39

(-2.8%)

Market Cap (In USD)

14.77 Million

Revenue (In USD)

13.85 Million

Net Income (In USD)

-22.13 Million

Avg. Volume

2.47 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.46-9.1
PE
-0.42
EPS
-3.33
Beta Value
2.076
ISIN
IL0011331076
CUSIP
-
CIK
1607962
Shares
10630300.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Lawrence J. Jasinski BS, MBA
Employee Count
-
Website
https://www.rewalk.com
Ipo Date
2014-09-12
Details
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.